UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 46

Sortiert nach

Inactivating mutations of the histone methyltransferase gene EZH2 in myeloid disorders

Nature genetics, 2010-08, Vol.42 (8), p.722-726

2010

Volltextzugriff (PDF)

Frequent CBL mutations associated with 11q acquired uniparental disomy in myeloproliferative neoplasms

Blood, 2009-06, Vol.113 (24), p.6182-6192

2009

Volltextzugriff (PDF)

A constitutively active SPTBN1-FLT3 fusion in atypical chronic myeloid leukemia is sensitive to tyrosine kinase inhibitors and immunotherapy

Experimental hematology, 2007-11, Vol.35 (11), p.1723-1727

2007

Volltextzugriff (PDF)

Widespread occurrence of the JAK2 V617F mutation in chronic myeloproliferative disorders

Blood, 2005-09, Vol.106 (6), p.2162-2168

2005

Volltextzugriff (PDF)

Activity of TKI258 against primary cells and cell lines with FGFR1 fusion genes associated with the 8p11 myeloproliferative syndrome

Blood, 2007-11, Vol.110 (10), p.3729-3734

2007

Volltextzugriff (PDF)

Identification of FOXP1 and SNX2 as novel ABL1 fusion partners in acute lymphoblastic leukaemia

British journal of haematology, 2011-04, Vol.153 (1), p.43-46

2011

Volltextzugriff (PDF)

Two novel imatinib‐responsive PDGFRA fusion genes in chronic eosinophilic leukaemia

British journal of haematology, 2007-07, Vol.138 (1), p.77-81

2007

Volltextzugriff (PDF)

The t(1;9)(p34;q34) and t(8;12)(p11;q15) fuse pre-mRNA processing proteins SFPQ (PSF) and CPSF6 to ABL and FGFR1

Genes chromosomes & cancer, 2008-05, Vol.47 (5), p.379-385

2008

Volltextzugriff (PDF)

Identification of a novel gene, FGFR1OP2, fused to FGFR1 in 8p11 myeloproliferative syndrome

Genes chromosomes & cancer, 2004-05, Vol.40 (1), p.78-83

2004

Volltextzugriff (PDF)

p53-Binding protein 1 is fused to the platelet-derived growth factor receptor β in a patient with a t(5;15)(q33;q22) and an imatinib-responsive eosinophilic myeloproliferative disorder

Cancer research (Chicago, Ill.), 2004-10, Vol.64 (20), p.7216-7219

2004

Volltextzugriff (PDF)

The t(1;9)(p34;q34) fusing ABL1 with SFPQ , a pre-mRNA processing gene, is recurrent in acute lymphoblastic leukemias

Leukemia research, 2011-07, Vol.35 (7), p.e114-e117

2011

Volltextzugriff (PDF)

Fusion of PDGFRB to two distinct loci at 3p21 and a third at 12q13 in imatinib‐responsive myeloproliferative neoplasms

British journal of haematology, 2010-01, Vol.148 (2), p.268-273

2010

Volltextzugriff (PDF)

Der(6)t(1;6)(q21–23;p21.3): a specific cytogenetic abnormality in myelofibrosis with myeloid metaplasia

British journal of haematology, 2005-07, Vol.130 (2), p.229-232

2005

Volltextzugriff (PDF)

NUP98-LEDGF fusion and t(9;11) in transformed chronic myeloid leukemia

Leukemia research, 2005-12, Vol.29 (12), p.1469-1472

2005

Volltextzugriff (PDF)

Chromatin Conformation Signatures Associated with Epigenetic Deregulation of the FIP1L1 and PDGFRA Genes

Blood, 2016-12, Vol.128 (22), p.1525-1525

2016

Volltextzugriff (PDF)

TKI258 (CHIR-258) Selectively Inhibits FGFR1 Fusion Genes Associated with the 8p11 Myeloproliferative Syndrome

Blood, 2006-11, Vol.108 (11), p.2699-2699

2006

Volltextzugriff (PDF)

SPTBN1-FLT3 in Atypical Chronic Myeloid Leukemia Transforms Ba/F3 Cells to IL-3 Independence and Is Sensitive to Both Tyrosine Kinase Inhibitors and Immunotherapy

Blood, 2005-11, Vol.106 (11), p.2009-2009

2005

Volltextzugriff (PDF)

The Platelet-Derived Growth Factor Receptor beta Fuses to Two Distinct Loci at 3p21 in Imatinib Responsive Chronic Eosinophilic Leukemia

Blood, 2005-11, Vol.106 (11), p.3253-3253

2005

Volltextzugriff (PDF)

Fusion of SFQP to ABL in a Patient with a T(1;9)(p34;q34) and Acute Lymphocytic Leukemia

Blood, 2004-11, Vol.104 (11), p.4444-4444

2004

Volltextzugriff (PDF)

Abnormal Patterns of Immunoglobulin Heavy Chain Gene DNA Fingerprinting During Chronic Phase Chronic Myeloid Leukemia

Leukemia & lymphoma, 1999, Vol.32 (3-4), p.299-307

1999

Volltextzugriff (PDF)

Tetrahydrofuran-Based Transient Receptor Potential Ankyrin 1 (TRPA1) Antagonists: Ligand-Based Discovery, Activity in a Rodent Asthma Model, and Mechanism-of-Action via Cryogenic Electron Microscopy

Journal of medicinal chemistry, 2021-04, Vol.64 (7), p.3843-3869

2021

Volltextzugriff (PDF)

Ranibizumab and Bevacizumab for Treatment of Neovascular Age-related Macular Degeneration: Two-Year Results

Ophthalmology (Rochester, Minn.), 2012-07, Vol.119 (7), p.1388-1398

2012

Volltextzugriff (PDF)

Ranibizumab and Bevacizumab for Neovascular Age-Related Macular Degeneration

The New England journal of medicine, 2011-05, Vol.364 (20), p.1897-1908

2011

Volltextzugriff (PDF)

Genetic variants near TIMP3 and high-density lipoprotein-associated loci influence susceptibility to age-related macular degeneration

Proceedings of the National Academy of Sciences - PNAS, 2010-04, Vol.107 (16), p.7401-7406

2010

Volltextzugriff (PDF)

1 – 25 von 46

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(44)
Mit Volltextzugriff
(40)

Publikationsform

Artikel
(45)
Bücher
(1)

Sprache

Englisch
(46)
Japanisch
(8)

Erscheinungsjahr

n.n

Thema

Humans
(36)
Science & Technology
(33)
Life Sciences & Biomedicine
(31)
Male
(22)
Female
(19)
Aged
(15)
Ophthalmology
(14)
Angiogenesis Inhibitors - Therapeutic Use
(11)
Tomography, Optical Coherence
(11)
Bevacizumab
(10)
Biological And Medical Sciences
(10)
Fluorescein Angiography
(10)
Middle Aged
(10)
Ranibizumab
(10)
Hematology
(9)
Medical Sciences
(9)
Prospective Studies
(9)
Vascular Endothelial Growth Factor A - Antagonists & Inhibitors
(9)
Aged, 80 And Over
(8)
Intravitreal Injections
(8)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Inactivating mutations of the histone methyltransferase gene EZH2 in myeloid disorders

Frequent CBL mutations associated with 11q acquired uniparental disomy in myeloproliferative neoplasms

A constitutively active SPTBN1-FLT3 fusion in atypical chronic myeloid leukemia is sensitive to tyrosine kinase inhibitors and immunotherapy

Widespread occurrence of the JAK2 V617F mutation in chronic myeloproliferative disorders

Activity of TKI258 against primary cells and cell lines with FGFR1 fusion genes associated with the 8p11 myeloproliferative syndrome

Identification of FOXP1 and SNX2 as novel ABL1 fusion partners in acute lymphoblastic leukaemia

Two novel imatinib‐responsive PDGFRA fusion genes in chronic eosinophilic leukaemia

The t(1;9)(p34;q34) and t(8;12)(p11;q15) fuse pre-mRNA processing proteins SFPQ (PSF) and CPSF6 to ABL and FGFR1

Identification of a novel gene, FGFR1OP2, fused to FGFR1 in 8p11 myeloproliferative syndrome

p53-Binding protein 1 is fused to the platelet-derived growth factor receptor β in a patient with a t(5;15)(q33;q22) and an imatinib-responsive eosinophilic myeloproliferative disorder

The t(1;9)(p34;q34) fusing ABL1 with SFPQ , a pre-mRNA processing gene, is recurrent in acute lymphoblastic leukemias

Fusion of PDGFRB to two distinct loci at 3p21 and a third at 12q13 in imatinib‐responsive myeloproliferative neoplasms

Der(6)t(1;6)(q21–23;p21.3): a specific cytogenetic abnormality in myelofibrosis with myeloid metaplasia

NUP98-LEDGF fusion and t(9;11) in transformed chronic myeloid leukemia

Chromatin Conformation Signatures Associated with Epigenetic Deregulation of the FIP1L1 and PDGFRA Genes

TKI258 (CHIR-258) Selectively Inhibits FGFR1 Fusion Genes Associated with the 8p11 Myeloproliferative Syndrome

SPTBN1-FLT3 in Atypical Chronic Myeloid Leukemia Transforms Ba/F3 Cells to IL-3 Independence and Is Sensitive to Both Tyrosine Kinase Inhibitors and Immunotherapy

The Platelet-Derived Growth Factor Receptor beta Fuses to Two Distinct Loci at 3p21 in Imatinib Responsive Chronic Eosinophilic Leukemia

Fusion of SFQP to ABL in a Patient with a T(1;9)(p34;q34) and Acute Lymphocytic Leukemia

Abnormal Patterns of Immunoglobulin Heavy Chain Gene DNA Fingerprinting During Chronic Phase Chronic Myeloid Leukemia

Tetrahydrofuran-Based Transient Receptor Potential Ankyrin 1 (TRPA1) Antagonists: Ligand-Based Discovery, Activity in a Rodent Asthma Model, and Mechanism-of-Action via Cryogenic Electron Microscopy

Identification of a Titin-derived HLA-A1-presented peptide as a cross-reactive target for engineered MAGE A3-directed T cells

Ranibizumab and Bevacizumab for Treatment of Neovascular Age-related Macular Degeneration: Two-Year Results

Ranibizumab and Bevacizumab for Neovascular Age-Related Macular Degeneration

Genetic variants near TIMP3 and high-density lipoprotein-associated loci influence susceptibility to age-related macular degeneration

Suchergebnisse filtern